INTERNATIONAL PATENT: FUSION PHARMACEUTICALS INC. FILES APPLICATION FOR "PSMA-TARGETED RADIOPHARMACEUTICALS FOR TREATMENT OF CANCER"

GENEVA, June 29 -- FUSION PHARMACEUTICALS INC. (270 Longwood Road SouthHamilton, Ontario L8P 0A6) filed a patent application (PCT/CA2024/051689) for "PSMA-TARGETED RADIOPHARMACEUTICALS FOR TREATMENT OF CANCER" on Dec 18, 2024. With publication no. WO/2025/129334, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): O'LEARY, James (273 Watertown StreetNewton, Massachusetts 02458), BOBILEV, Dmitri (760 Dedham StreetNewton, Massachusetts 02459), SCHINDLER, Joanne Elizabeth Sarah (41 Oldfield DriveSherborn, Massachusetts 01770), R...